Verition Fund Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,320
| Closed | -$140K | – | 3159 |
|
|
2025
Q1 | $140K | Sell |
20,320
-42,840
| -68% | -$296K | ﹤0.01% | 2447 |
|
|
2024
Q4 | $335K | Buy |
+63,160
| New | +$335K | ﹤0.01% | 2091 |
|
|
2021
Q2 | – | Sell |
-12,125
| Closed | -$113K | – | 2045 |
|
|
2021
Q1 | $113K | Buy |
+12,125
| New | +$113K | ﹤0.01% | 1308 |
|
|
2018
Q2 | – | Sell |
-11,416
| Closed | -$48K | – | 1292 |
|
|
2018
Q1 | $48K | Buy |
+11,416
| New | +$48K | ﹤0.01% | 1027 |
|